ProTreat: an adaptive and rapid implementation trial of novel therapies to prevent and treat COVID-19 infection in high risk cancer patients
- Funded by Australian Government (Australian Research Council)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$3,935,388.68Funder
Australian Government (Australian Research Council)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
University of MelbourneResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Clinical trial (unspecified trial phase)
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient